Dasatinib Accord Healthcare

Medicinal product

(Invented) name

Dasatinib Accord Healthcare

Active substance (s)

Dazatinibas

Strength

20 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

Accord Healthcare S.L.U., Ispanija

Date of authorisation

2024-07-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dazatinibas	20 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114671	100778	1100778	lizdinė plokštelė	N56		Receptinis	EU/1/24/1839/001	Netiekiama	-	-	No	-	-
114672	100779	1100779	lizdinė plokštelė	N60		Receptinis	EU/1/24/1839/002	Netiekiama	-	-	No	-	-
114673	100780	1100780	dalomoji lizdinė plokštelė	N56×1		Receptinis	EU/1/24/1839/003	Netiekiama	-	-	No	-	-
114674	100781	1100781	dalomoji lizdinė plokštelė	N60×1		Receptinis	EU/1/24/1839/004	Netiekiama	-	-	No	-	-
118370	104476	1104476	dalomoji lizdinė plokštelė	N10×1		Receptinis	EU/1/24/1839/025	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-26	Registruotas